By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
New Delhi: The death toll in the cough syrup tragedy has risen to 15 in Madhya Pradesh's Chhindwara as one more child died due to kidney failure in the district after allegedly consuming contaminated 'Coldrif' syrup.
Dhani Dehariya, a resident of Tamia, Chhindwara, had been admitted to a hospital since September 26 and was treated by Praveen Soni, a Chhindwara-based doctor who is at the centre of the cough syrup tragedy. The girl aged one and a half year died late last night due to kidney failure.
MP paediatrician arrested
Madhya Pradesh Police on Sunday arrested Praveen Soni, a senior paediatrician, for alleged negligence, following a massive row over the recent child deaths and hospitalisations allegedly linked to the contaminated cough syrup. Soni, a government doctor who prescribed the syrup to children after they visited his private clinic, was also suspended.
On Monday, several states put a restriction on the supply and consumption of Coldrif cough syrup following several fatalities of children linked to the medicine in Madhya Pradesh, where the government suspended three officials and transferred the drug controller. On Tuesday, Punjab joined the list of states --Madhya Pradesh, Rajasthan and Uttarakhand -- that have banned the sale of the cough syrup.
PIL in SC over cough syrup tragedy
Meanwhile, a PIL has been filed in the Supreme Court demanding a nationwide ban and recall of all contaminated cough syrup batches, compensation for the bereaved families and formation of a committee to audit and recommend drug-safety reforms. The petitioner, Vihal Tiwari, said that the country witnessed "yet another man-made tragedy that tore through the conscience of the nation" — the deaths of children after consuming contaminated cough syrup.
The plea further said that laboratory tests conducted by Madhya Pradesh government confirmed that Coldrif cough syrup, manufactured by Tamil Nadu-based Sresan Pharma Pvt Ltd, Tamil Nadu, contained diethylene glycol -- a highly toxic industrial solvent prohibited for pharmaceutical use.
The petitioner said that the incident exposes India’s broken pharmaceutical surveillance network. "The tragedy is not of chance but of negligence, apathy, and regulatory failure — an institutional rot that allows counterfeit and adulterated drugs to enter the public market unchecked," the plea stated.